
Faslodex Coupons & Savings Card – Discount Prices from $82.80
Brand for: Fulvestrant
My prescription
Edit
5ML of 250MG/5ML, Fulvestrant (1 Syringe)
Select pharmacy

CVS
$848.74
COUPON PRICE
Walgreens
$82.80
COUPON PRICE
Albertsons
$144.77
COUPON PRICE
Walmart
$506.75
COUPON PRICEFaslodex savings card
Show this card to your pharmacist
Walgreens
$82.80
BIN
ID
PCN
GRP
019876
LH1E288D3A
CHIPPO
LHX
Powered by
Related estrogen antagonists prescriptions
More prescriptions for breast cancer
Related estrogen antagonists prescriptions
More prescriptions for breast cancer
Faslodex (Fulvestrant) dosage forms
Dosage Quantity Price from Per unit 5ML of 250MG/5ML 1 Syringe $82.80 $82.80 5ML of 250MG/5ML 2 Syringes $156.60 $78.30 5ML of 250MG/5ML 3 Syringes $230.40 $76.80
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 5ML of 250MG/5ML | 1 Syringe | $82.80 | $82.80 |
| 5ML of 250MG/5ML | 2 Syringes | $156.60 | $78.30 |
| 5ML of 250MG/5ML | 3 Syringes | $230.40 | $76.80 |
Is Faslodex a form of chemotherapy?
Faslodex is not a form of chemotherapy. It is a type of hormone therapy used to treat certain types of breast cancer by blocking the effects of estrogen in the body.
What is Faslodex used for?
Faslodex is used for the treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women. It is often prescribed when the cancer has progressed following anti-estrogen therapy.
When should I stop taking fulvestrant?
The decision to stop taking fulvestrant should be made in consultation with a healthcare provider. It is typically based on factors such as the effectiveness of the treatment, side effects experienced, and the progression of the condition being treated. It is important for the patient to follow the guidance of their oncologist or healthcare team regarding the duration of treatment with fulvestrant.
Is Faslodex chemotherapy or immunotherapy?
Faslodex is neither chemotherapy nor immunotherapy. It is a type of hormone therapy used to treat certain types of breast cancer.
What is the survival rate for Faslodex?
The survival rate for patients taking Faslodex (fulvestrant) can vary depending on several factors, including the stage of breast cancer, previous treatments, and individual patient characteristics. Faslodex is commonly used in hormone receptor-positive metastatic breast cancer, often in postmenopausal women. Clinical trials have shown that Faslodex can improve progression-free survival, but overall survival rates can differ based on the specific clinical context and combination with other therapies. It is important for patients to discuss their individual prognosis and treatment outcomes with their healthcare provider.
